Blueprint Medicines Corp (NASDAQ: BPMC) – Suitable For Long Term Buy?
Currently, there are 64.56M common shares owned by the public and among those 62.21M shares have been available to trade. The company’s stock has a 5-day price change of 0.14% and 47.62% over the past three months. BPMC shares are trading 46.72% year to date (YTD), with the 12-month market performance up to 20.93% higher. […]
Growing Through Challenges? – Blueprint Medicines Corp (BPMC)
Currently, there are 64.56M common shares owned by the public and among those 62.21M shares have been available to trade. The company’s stock has a 5-day price change of 25.90% and 42.38% over the past three months. BPMC shares are trading 46.51% year to date (YTD), with the 12-month market performance up to 27.07% higher. […]